Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Teva Pharmaceutical Industries has temporarily suspended sales of a generic version of Novartis's herpes treatment Famvir following an injunction from the US court of appeals.
Subscribe to our email newsletter
Teva said that the court has issued an order temporarily enjoining the company from further sales of generic Famciclovir tablets, AB-rated to Novartis’s Famvir tablets. The injunction will remain in place pending consideration of Novartis’s emergency motion for a stay pending appeal.
Israel-based Teva said that its response to Novartis’s emergency motion is due on September 11, 2007.